Building business partnerships in human and animal health

Parties with an interest to tackle major challenges related to infectious diseases in both humans and animals, in collaboration with appropriate business partners, turn to Immuno Valley. We effectively match business and science to specifically build, nurture, and support lasting business partnerships for R&D. Read more about How We Work>

Contact us

Interested in Immuno Valley Network or Services? 
Call us: +31 (0) 30 253 1142
Send an email:



  1. New call for proposals open in ZonMW Antibiotic Resistance programme

    The general Antibiotic Resistance programme funds research designed to help fight antibiotic resistance and/or identify points of action for the development of new antibiotics or interventions. The ambition is to reduce antibiotic resistance within five years following publication of project results. Read more...

  2. ZonMw Antibiotic Resistance grant to study drug-resistant Gram-negative bacteria

    Nathaniel Martin (Utrecht University, Pharmaceutical Sciences) has been awarded a ZonMw grant of 500,000 Euros to study drug-resistant Gram-negative bacteria. Working together with Suzan Rooijakkers (UMC Utrecht) and Oscar Kuipers (University of Groningen), partners in the granted ZonMw project, Martin will investigate different combinations of drugs that could work in synergy to kill such drug-resistant Gram-negative pathogens. Read more...

  3. Start of 3 new Lyme disease research projects with ZonMw funding

    The ZonMW Program Committee on Lyme disease, has gathered advice from patients and international Lyme experts and decided to approve 3 new studies into Lyme disease. The project will set off in the summer of 2017. They are part of the Action plan on Lyme disease. Read more...

More news


  1. Superbugs & Superdrugs 2017

    On 20-21 March 2017, the industry’s premier event on antibiotic resistance will provide a perfect platform for its growing "superbugs" community to network, exchange novel solutions and consolidate current strategies.

  2. Bio Europe Spring 2017

    The premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe's most innovative biopharma clusters.

  3. 4th Microbiome R&D and Business Collaboration Forum: Europe

    As part of its worldwide microbiome series, Global Engage is pleased to announce the Microbiome R&D and Business Collaboration Forum: Europe which will be held on 3 – 4 April, 2017.

  4. ALTANT Closing event

    More information about the program will follow.